Total Payments
$325,421
2024 Payments
$61,836
Companies
22
Transactions
540
Medicare Patients
3,841
Medicare Billing
$334,905
Payment Breakdown by Category
Other$237,286 (72.9%)
Consulting$51,364 (15.8%)
Travel$18,105 (5.6%)
Food & Beverage$12,012 (3.7%)
Education$6,654 (2.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $237,286 | 112 | 72.9% |
| Consulting Fee | $51,364 | 17 | 15.8% |
| Travel and Lodging | $18,105 | 69 | 5.6% |
| Food and Beverage | $12,012 | 317 | 3.7% |
| Education | $6,654 | 25 | 2.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Actelion Pharmaceuticals US, Inc. | $148,151 | 202 | $0 (2024) |
| United Therapeutics Corporation | $132,849 | 197 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $30,886 | 44 | $0 (2024) |
| Merck Sharp & Dohme LLC | $11,690 | 23 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $322.67 | 14 | $0 (2024) |
| Abbott Laboratories | $313.33 | 8 | $0 (2024) |
| Genentech USA, Inc. | $269.60 | 12 | $0 (2019) |
| Sandoz Inc. | $214.51 | 9 | $0 (2023) |
| Novo Nordisk Inc | $194.99 | 7 | $0 (2022) |
| Insmed, Inc. | $158.87 | 4 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $61,836 | 93 | Actelion Pharmaceuticals US, Inc. ($30,658) |
| 2023 | $60,305 | 116 | Actelion Pharmaceuticals US, Inc. ($27,553) |
| 2022 | $60,467 | 86 | Actelion Pharmaceuticals US, Inc. ($46,899) |
| 2021 | $38,451 | 54 | Actelion Pharmaceuticals US, Inc. ($18,754) |
| 2020 | $23,986 | 28 | United Therapeutics Corporation ($12,881) |
| 2019 | $37,651 | 75 | United Therapeutics Corporation ($20,166) |
| 2018 | $17,617 | 41 | United Therapeutics Corporation ($13,805) |
| 2017 | $25,108 | 47 | United Therapeutics Corporation ($15,562) |
All Payment Transactions
540 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | United Therapeutics Corporation | TYVASO (Drug) | Travel and Lodging | Cash or cash equivalent | $609.97 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 12/24/2024 | United Therapeutics Corporation | TYVASO (Drug) | Travel and Lodging | Cash or cash equivalent | $323.44 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 12/24/2024 | United Therapeutics Corporation | TYVASO (Drug) | Travel and Lodging | Cash or cash equivalent | $16.00 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 12/17/2024 | United Therapeutics Corporation | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $485.00 | General |
| 12/06/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $35.21 | General |
| Category: Cardiology | ||||||
| 12/04/2024 | United Therapeutics Corporation | — | Consulting Fee | Cash or cash equivalent | $2,425.00 | General |
| 12/04/2024 | United Therapeutics Corporation | — | Food and Beverage | In-kind items and services | $64.99 | General |
| 12/04/2024 | United Therapeutics Corporation | — | Food and Beverage | In-kind items and services | $64.04 | General |
| 12/04/2024 | United Therapeutics Corporation | — | Food and Beverage | In-kind items and services | $49.27 | General |
| 12/04/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $44.52 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 11/20/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,270.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/20/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,135.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/20/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Travel and Lodging | Cash or cash equivalent | $150.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/18/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Travel and Lodging | Cash or cash equivalent | $150.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/15/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $28.30 | General |
| Category: Heart Failure | ||||||
| 11/08/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $39.23 | General |
| Category: Cardiology | ||||||
| 11/05/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $33.55 | General |
| Category: Heart Failure | ||||||
| 10/29/2024 | INOGEN, INC. | INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH (Device) | Food and Beverage | Cash or cash equivalent | $12.52 | General |
| Category: OXYGEN CONCENTRATOR | ||||||
| 10/28/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $115.89 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/28/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $26.03 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/25/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $12.13 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/22/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,270.00 | General |
| Category: Cardiology | ||||||
| 10/17/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $137.13 | General |
| Category: Cardiology | ||||||
| 10/14/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Consulting Fee | Cash or cash equivalent | $4,905.00 | General |
| Category: Cardiology | ||||||
| 10/14/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $34.74 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 787 | 1,060 | $238,496 | $82,470 |
| 2022 | 22 | 1,014 | 1,234 | $177,221 | $66,945 |
| 2021 | 22 | 1,090 | 1,582 | $247,283 | $102,611 |
| 2020 | 24 | 950 | 1,309 | $203,553 | $82,879 |
Total Patients
3,841
Total Services
5,185
Medicare Billing
$334,905
Procedure Codes
93
All Medicare Procedures & Services
93 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 25 | 151 | $33,425 | $13,772 | 41.2% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 11 | 66 | $30,396 | $10,886 | 35.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 69 | 93 | $27,846 | $9,738 | 35.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 113 | 127 | $26,544 | $8,516 | 32.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 51 | 51 | $18,507 | $6,532 | 35.3% |
| 93451 | Insertion of tube in right heart chambers for measurement | Facility | 2023 | 56 | 57 | $17,772 | $5,500 | 30.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 53 | 53 | $14,446 | $4,917 | 34.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 36 | 46 | $11,280 | $4,151 | 36.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 26 | 32 | $12,263 | $4,088 | 33.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 28 | 57 | $8,630 | $3,416 | 39.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 20 | 25 | $8,603 | $3,347 | 38.9% |
| 93463 | Drug infusion during cardiac catheterization | Facility | 2023 | 27 | 27 | $5,755 | $2,023 | 35.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 13 | 14 | $2,916 | $1,231 | 42.2% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2023 | 12 | 13 | $3,572 | $1,121 | 31.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 19 | 19 | $2,848 | $964.44 | 33.9% |
| 76937 | Ultrasonic guidance for blood vessel access | Facility | 2023 | 54 | 55 | $1,518 | $602.80 | 39.7% |
| 94618 | Test for exercise-induced lung stress | Facility | 2023 | 26 | 26 | $1,456 | $444.60 | 30.5% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 39 | 39 | $1,160 | $352.25 | 30.4% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 35 | 35 | $3,725 | $335.65 | 9.0% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 35 | 35 | $4,972 | $270.18 | 5.4% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 39 | 39 | $862.00 | $261.49 | 30.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 28 | 114 | $21,590 | $8,928 | 41.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 95 | 116 | $20,232 | $8,215 | 40.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 66 | 66 | $16,973 | $6,705 | 39.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 22 | 38 | $16,571 | $6,093 | 36.8% |
About Dr. John Kingrey, MD
Dr. John Kingrey, MD is a Internal Medicine healthcare provider based in Oklahoma City, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/23/2007. The National Provider Identifier (NPI) number assigned to this provider is 1689863953.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Kingrey, MD has received a total of $325,421 in payments from pharmaceutical and medical device companies, with $61,836 received in 2024. These payments were reported across 540 transactions from 22 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($237,286).
As a Medicare-enrolled provider, Kingrey has provided services to 3,841 Medicare beneficiaries, totaling 5,185 services with total Medicare billing of $334,905. Data is available for 4 years (2020–2023), covering 93 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Critical Care Medicine, Pulmonary Disease
- Location Oklahoma City, OK
- Active Since 10/23/2007
- Last Updated 09/25/2017
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1689863953
Products in Payments
- UPTRAVI (Drug) $116,270
- TYVASO (Drug) $32,708
- Adempas (Drug) $30,886
- REMODULIN (Drug) $27,053
- ORENITRAM (Drug) $21,726
- OPSUMIT (Drug) $20,872
- WINREVAIR (Biological) $11,391
- NONE (Drug) $10,710
- OPSUMIT MACITENTAN (Drug) $312.53
- OFEV (Drug) $308.98
- TREPROSTINIL (Drug) $214.51
- Circulatory Support (Device) $172.83
- Wegovy (Drug) $161.35
- Xolair (Biological) $142.88
- Arikayce (Drug) $138.16
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) $129.33
- Esbriet (Biological) $126.72
- Impella (Device) $77.06
- BOSENTAN (Drug) $75.84
- INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH (Device) $51.52
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Oklahoma City
Dr. Jeffrey Sparling, M.d, M.D
Internal Medicine — Payments: $289,451
Internal Medicine $289,451
Dr. Romeo Mandanas, M.d, M.D
Internal Medicine — Payments: $275,924
Internal Medicine $275,924
Marcus Smith, Md, MD
Internal Medicine — Payments: $181,269
Internal Medicine $181,269
Dr. Ryan Morgan, D.o, D.O
Internal Medicine — Payments: $126,341
Internal Medicine $126,341
Usman Baber, Md, MD
Internal Medicine — Payments: $76,000
Internal Medicine $76,000
Dr. Krittapoom Akrawinthawong, M.d, M.D
Internal Medicine — Payments: $74,128
Internal Medicine $74,128